The impossibility of exhaustively defining the legal framework applicable to future medical research, arising from the unpredictability of the methods and progress of biomedicine, leads to the effort to try post-factum regulation, with all the related disadvantages, the most important being, by far, the appearance of biomedical applications or results of medical research that tests the limits of current law.An example of this is xenotra...